- Recent Funding
- Investors
- China Grand Pharmaceutical and Healthcare Holdings
China Grand Pharmaceutical and Healthcare Holdings portfolio
China Grand Pharmaceutical and Healthcare Holdings has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It led 2 of the 3 rounds it joined. Its most recent investment on record is Cavendish Biotechnology's Series A round in October 2026, which it led. By category, its portfolio leans toward Health and bio (3) and Manufacturing and industrial (2). It has co-invested with Panakes Partners, Genextra and Indaco Venture Partners.
What China Grand Pharmaceutical and Healthcare Holdings invests in
- Health and bio · 3 · 100%
- Manufacturing and industrial · 2 · 67%
China Grand Pharmaceutical and Healthcare Holdings recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| CCavendish Biotechnology | Series A · lead | none named | |
| Series B+ · $55M · lead | Panakes Partners, Genextra, Indaco Venture Partners | ||
| Series B+ · $38.41M | Yijing Capital, LSP, Fund+ +5 |
How China Grand Pharmaceutical and Healthcare Holdings invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 2 67% | $93.41M |
| Series A | 1 33% | undisclosed |
China Grand Pharmaceutical and Healthcare Holdings portfolio companies
- CCavendish BiotechnologySeries A · Oct 2026
IInnovHeart$55MSeries B+ · Jan 2022
EeTheRNA Immunotherapies$38.41MSeries B+ · Jun 2020
| Company | Round with China Grand Pharmaceutical and Healthcare Holdings | Total raised | Latest raise |
|---|---|---|---|
| CCavendish Biotechnology Health and bio |
Series A · lead | undisclosed | Oct 26, 2026 Series A |
Health and bio |
Series B+ · $55M · lead | $78.63M | Jan 27, 2022 Series B+ |
Health and bio |
Series B+ · $38.41M | $104.41M | Aug 24, 2022 Series B+ |
Most frequent co-investors
PPanakes Partners1 shared round · last Jan 27, 2022
GGenextra1 shared round · last Jan 27, 2022
IIndaco Venture Partners1 shared round · last Jan 27, 2022
PPMV1 shared round · last Jun 16, 2020
OOmega Funds1 shared round · last Jun 16, 2020
BBoehringer Ingelheim Venture Fund1 shared round · last Jun 16, 2020
FFund+1 shared round · last Jun 16, 2020
NNovalis LifeSciences1 shared round · last Jun 16, 2020
BBNP Paribas Private Equity1 shared round · last Jun 16, 2020
YYijing Capital1 shared round · last Jun 16, 2020
- LLSP1 shared round · last Jun 16, 2020
Similar investors
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 3 rounds on Recent Funding that name China Grand Pharmaceutical and Healthcare Holdings. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists China Grand Pharmaceutical and Healthcare Holdings, which is a subset of its real portfolio. API: /api/v1/investors/china-grand-pharmaceutical-and-healthcare-holdings (get a free API key). More: the most active VC firms and new venture capital funds.